Yıl: 2011 Cilt: 57 Sayı: 1 Sayfa Aralığı: 38 - 44 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Parkinson hastalığı ve rehabilitasyonu

Öz:
Parkinson hastalığı, bradikinezi, rijidite, istirahat tremoru ve postüral instabilite ile karakterize, kronik progresif dejeneratif bir hareketbozukluğudur. Bu temel bulgular dışında fleksiyon postürü, mimiklerde azalma, dizartri, yürürken kol salınımı kaybı gibi sekonder motor belirtiler ve kognitif bozukluklar, otonomik düzensizlikler, demans, uyku bozuklukları, ağrı, koku alma bozukluğu gibi belirtiler de Parkinson hastalığında görülebilir. Parkinson hastalığının temel nöropatolojik bulgusu substansia nigrada bulunan dopaminerjik nöronların kaybı ve sitoplazmik eosinofilik Lewy cisimciklerinin varlığıdır. Hastalık patogenezinden genetik ve çevresel faktörler birlikte sorumlu tutulmaktadır. Medikal tedavi hastalığın motor semptomlarını kontrol altına alırken rehabilitasyon yaklaşımları hastaların yaşam kalitesinin ve fonksiyonel kapasitelerinin iyileştirilmesi açısından önem taşır. Hastalığın erken evrelerinde rehabilitasyon programına başlanmalı, her hastaya göre bireysel program hazırlanarak tedavide süreklilik hedeflenmelidir. Türk Fiz Tıp Rehab Derg 2011;57:38-44. Anahtar Kelimeler: Parkinson hastalığı, patogenez, belirtiler, tedavi, Rehabilitasyon
Anahtar Kelime:

Konular: Rehabilitasyon

Parkinson’s disease and rehabilitation

Öz:
Parkinson’s disease is a chronic progressive neurodegenerative movement disorder, characterized by bradykinesia, rigidity, rest tremor and postural instability. In addition to these cardinal motor symptoms, secondary motor symptoms (e.g. flexion posture, hypomimia, dysarthria, loss of arm swing) and non-motor symptoms (e.g. cognitive impairments, autonomic disturbances, dementia, sleep disorders, pain, hyposmia) appear in Parkinson’s disease. The neuropathologic features of Parkinson’s disease are dopaminergic neuronal loss in the substantia nigra and the presence of cytoplasmic eosinophilic Lewy bodies. Genetic susceptibility and environmental factors share the responsibility in the pathogenesis of the disease. Although medical therapy may provide an effective control of motor symptoms, rehabilitation is an important treatment approach for improvement of quality of life and functional capacity of the patients. Individual rehabilitation program should be initiated in the early stages of the disease and treatment continuity should be targeted.Turk J Phys Med Rehab 2011;57:38-44.
Anahtar Kelime:

Konular: Rehabilitasyon
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 2002;14:223-36.
  • 2. Björklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007;30:194-202.
  • 3. de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meché FG, et al. Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study. Neurology 1995;45:2143-6.
  • 4. Cookson MR, Xiromerisiou G, Singleton A. How genetics research in Parkinson’s disease is enhancing understanding of the common idiopathic forms of the disease. Curr Opin Neurol 2005;18:706-11.
  • 5. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurology 2008;70:583-90.
  • 6. Hardy J. Genetic Analysis of Pathways to Parkinson Disease. Neuron 2010;68:201-6.
  • 7. Schulz JB. Update on the pathogenesis of Parkinson's disease. J Neurol 2008;255:3-7.
  • 8. McNaught KS, Jnobaptiste R, Jackson T, Jengelley TA. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease. Synapse 2010;64:241-50.
  • 9. Jancovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-76.
  • 10. Taylor KS, Counsell CE, Gordon JC, Harris CE. Screening for undiagnosed parkinsonism among older people in general practice. Age Ageing 2005;34:501-4.
  • 11. Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J, et al. Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study. Occup Environ Med 2007;64:666-72.
  • 12. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009;13:2055-66.
  • 13. Davie CA. A review of Parkinson’s disease. Br Med Bull 2008;86:109-27.
  • 14. Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging 2010;31:99-103.
  • 15. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 2002;249:1-5.
  • 16. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol 2001;58:1611-5.
  • 17. Lang AE. The progression of Parkinson disease: a hypothesis. Neurology 2007;68:948-52.
  • 18. Berardelli A, Rothwell JC, Thompson PD, Hallett M. Pathophysiology of bradykinesia in Parkinson’s disease. Brain 2001;124:2131-46.
  • 19. Stamey WP, Jankovic J. Shoulder pain in Parkinson’s disease. Mov Disord 2007;22:247-8.
  • 20. Bloch F, Houeto JL, Tezenas du, Montcel S, Bonneville F, Etchepare F, et al. Parkinson’s disease with camptocormia. J Neurol Neurosurg Psychiatry 2006;77:1223-8.
  • 21. Boonstra TA, van der Kooij H, Munneke M, Bloem BR. Gait disorders and balance disturbances in Parkinson's disease: clinical update and pathophysiology. Curr Opin Neurol 2008;21:461-71.
  • 22. Maurer C, Mergner T, Xie J, Faist M, Pollak P, Lücking CH. Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson’s disease. Brain 2003;126:1146-63.
  • 23. Hausdorff JM. Gait dynamics in Parkinson's disease: common and distinct behavior among stride length, gait variability, and fractal-like scaling. Chaos 2009;19:026113.
  • 24. Hunker CJ, Abbs JH, Barlow SM. The relationship between parkinsonian rigidity and hypokinesia in the orofacial system: a quantitative analysis. Neurology 1982;32:749-54.
  • 25. Critchley EM. Speech disorders of Parkinsonism: a review. J Neurol Neurosurg Psychiatry 1981;44:751-8.
  • 26. Sapir S, Ramig L, Fox C. Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg 2008;16:205-10.
  • 27. Jankovic J, Nour F. Respiratory dyskinesia in Parkinson's disease. Neurology 1986;36:303-4.
  • 28. Allcock LM, Ullyart K, Kenny RA, Burn DJ. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:1470-1.
  • 29. Hely MA, Morris JG, Reid WG, Trafficante R. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005;20:190-9.
  • 30. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;27:1863-72.
  • 31. Aarsland D, Brønnick K, Ehrt U, De Deyn PP, Tekin S, Emre M. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007;78:36-42.
  • 32. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-81.
  • 33. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol 2006;5:75-86.
  • 34. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-9.
  • 35. Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord 2002;17:867-76.
  • 36. Piccini P, Brooks DJ. New developments of brain imaging for Parkinson's disease and related disorders. Mov Disord 2006;21:2035-41.
  • 37. Ives NJ, Stowe RL, Marro J, Counsell C, Macleod A, Clarke CE, et al. Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients. BMJ 2004;329:593.
  • 38. Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010;25:578-86.
  • 39. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003;54:403-14.
  • 40. Buetow S, Giddings LS, Williams L, Nayar S; Parkinson's Society of New Zealand Members with Parkinson's Disease. Perceived unmet needs for health care among Parkinson's Society of New Zealand members with Parkinson's disease. Parkinsonism Relat Disord 2008;14:495-500.
  • 41. Morris ME, Martin CL, Schenkman ML. Striding out with Parkinson disease: evidence-based physical therapy for gait disorders. Phys Ther 2010;90:280-8.
  • 42. Dereli EE, Yaliman A. Comparison of the effects of a physiotherapist-supervised exercise programme and a self-supervised exercise programme on quality of life in patients with Parkinson's disease. Clin Rehabil 2010;24:352-62.
  • 43. Gracies JM. Neurorehabilitation in parkinsonian syndromes. Rev Neurol (Paris) 2010;166:196-212.
  • 44. Mehrholz J, Friis R, Kugler J, Twork S, Storch A, Pohl M. Treadmill training for patients with Parkinson's disease. Cochrane Database Syst Rev 2010;20:CD007830.
  • 45. Dibble LE, Addison O, Papa E. The effects of exercise on balance in persons with Parkinson's disease: a systematic review across the disability spectrum. J Neurol Phys Ther 2009;33:14-26.
  • 46. Ebersbach G, Edler D, Kaufhold O, Wissel J. Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson's disease. Arch Phys Med Rehabil 2008;89:399-403.
  • 47. Lowry KA, Carrel AJ, McIlrath JM, Smiley-Oyen AL. Use of harmonic ratios to examine the effect of cueing strategies on gait stability in persons with Parkinson's disease. Arch Phys Med Rehabil 2010;91:632-8.
  • 48. Ford MP, Malone LA, Nyikos I, Yelisetty R, Bickel CS. Gait training with progressive external auditory cueing in persons with Parkinson's disease. Arch Phys Med Rehabil 2010;91:1255-61.
  • 49. Nieuwboer A, Baker K, Willems AM, Jones D, Spildooren J, Lim I, et al. The short-term effects of different cueing modalities on turn speed in people with Parkinson's disease. Neurorehabil Neural Repair 2009;23:831-6.
  • 50. Tanaka K, Quadros AC Jr, Santos RF, Stella F, Gobbi LT, Gobbi S. Benefits of physical exercise on executive functions in older people with Parkinson's disease. Brain Cogn 2009;69:435-41.
  • 51. Mochizuki-Kawai H, Kawamura M, Hasegawa Y, Mochizuki S, Oeda R, Yamanaka K, et al. Deficits in long-term retention of learned motor skills in patients with cortical or subcortical degeneration. Neuropsychologia 2004;42:1858-63.
APA YALIMAN A, Şen E (2011). Parkinson hastalığı ve rehabilitasyonu. , 38 - 44.
Chicago YALIMAN AYSE,Şen Ekin İlke Parkinson hastalığı ve rehabilitasyonu. (2011): 38 - 44.
MLA YALIMAN AYSE,Şen Ekin İlke Parkinson hastalığı ve rehabilitasyonu. , 2011, ss.38 - 44.
AMA YALIMAN A,Şen E Parkinson hastalığı ve rehabilitasyonu. . 2011; 38 - 44.
Vancouver YALIMAN A,Şen E Parkinson hastalığı ve rehabilitasyonu. . 2011; 38 - 44.
IEEE YALIMAN A,Şen E "Parkinson hastalığı ve rehabilitasyonu." , ss.38 - 44, 2011.
ISNAD YALIMAN, AYSE - Şen, Ekin İlke. "Parkinson hastalığı ve rehabilitasyonu". (2011), 38-44.
APA YALIMAN A, Şen E (2011). Parkinson hastalığı ve rehabilitasyonu. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 57(1), 38 - 44.
Chicago YALIMAN AYSE,Şen Ekin İlke Parkinson hastalığı ve rehabilitasyonu. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 57, no.1 (2011): 38 - 44.
MLA YALIMAN AYSE,Şen Ekin İlke Parkinson hastalığı ve rehabilitasyonu. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, vol.57, no.1, 2011, ss.38 - 44.
AMA YALIMAN A,Şen E Parkinson hastalığı ve rehabilitasyonu. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2011; 57(1): 38 - 44.
Vancouver YALIMAN A,Şen E Parkinson hastalığı ve rehabilitasyonu. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2011; 57(1): 38 - 44.
IEEE YALIMAN A,Şen E "Parkinson hastalığı ve rehabilitasyonu." Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 57, ss.38 - 44, 2011.
ISNAD YALIMAN, AYSE - Şen, Ekin İlke. "Parkinson hastalığı ve rehabilitasyonu". Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 57/1 (2011), 38-44.